Compare Enzyme (MLN) vs Venom (VENOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Venom — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Venom is far larger — about 2.5× Enzyme's market cap, and Venom's supply is capped (988,9M / 8B VENOM (13%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Venom for 22 Days on average.
| MLN | VENOM | |
|---|---|---|
Market Cap | Rp134,13M | Rp340,86M |
Volume (24h) | Rp104,56M | Rp2,89M |
Circulating Supply | 3,3M MLN | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 28 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Venom (VENOM) currently holds a market capitalization of Rp340.86 million with a circulating supply of 988.9 million tokens (13% of max supply). The asset shows limited market activity with an average hold time of 22 days, indicating moderate trader retention. No recent protocol updates or significant ecosystem developments were identified during the analysis period.
Overall outlook remains cautious due to low circulation rate and limited market data. Key opportunities include potential future protocol development, while major risks involve low liquidity and the speculative nature of early-stage crypto assets. Investors should monitor for increased network adoption and exchange listings.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Venom
Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →
